Achieving postprandial glucose control with lixisenatide improves glycemic control in patients with type 2 diabetes on basal insulin: a post-hoc analysis of pooled data

BACKGROUND: To examine the impact on glycemic control of achieving postprandial glucose (PPG) target with lixisenatide, a once-daily glucagon-like peptide-1 receptor agonist approved in the US, in patients with uncontrolled type 2 diabetes (T2D) on basal insulin, an agent that primarily targets fast...

Descripción completa

Detalles Bibliográficos
Autores principales: Davidson, Jaime A., Stager, William, Paranjape, Sachin, Berria, Rachele, Leiter, Lawrence A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6961286/
https://www.ncbi.nlm.nih.gov/pubmed/31956422
http://dx.doi.org/10.1186/s40842-019-0088-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6961286/
https://www.ncbi.nlm.nih.gov/pubmed/31956422
http://dx.doi.org/10.1186/s40842-019-0088-5

Ejemplares similares